Majaribio ya kliniki ya Unenepu katika jimbo la Oklahoma
Masomo 21 ya Unenepu yanatafuta washiriki katika vituo vya jimbo la Oklahoma.
Miji katika jimbo la Oklahoma
Maandishi rasmi ya utafiti (Kiingereza)
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Children's Physicians OU, Oklahoma City
InaajiriHatua 3
Umri 8 hadi 18 · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT07253285Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- Lynn Health Science Institute, Oklahoma City
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07837973AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Lynn Institute of Norman, Norman
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07720271A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- University of Oklahoma Health Sciences Center, Oklahoma City
InaajiriHatua 3
Umri 6 hadi 17 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06672549Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Central States Research, Tulsa
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07353931A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Oklahoma City
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT07743450Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- South Oklahoma Heart Research, Oklahoma City
InaajiriHatua 3
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT07037459A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Lynn Institute of Norman, Norman
- Lynn Health Science Institute, Oklahoma City
- Essential Medical Research, Tulsa
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT07351058A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Alliance for Multispecialty Research, LLC, Norman
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT06897475A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Delricht Research of Tulsa Clinical Trials, Tulsa
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT07351045A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Moore
- ACCOMPLISH-2 Research Site, Tulsa
- ACCOMPLISH-2 Research Site, Yukon
InaajiriHatua 3Wajitolea wenye afya wanakaribishwa
Umri 18 hadi 79 · Jinsia zote · Imesasishwa 11 Sep 2026 · NCT07654374Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Chickasha
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 3 Sep 2026 · NCT07284901Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Alliance for Multispecialty Research - Norman, Norman
InaajiriHatua 3
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 3 Sep 2026 · NCT07684235Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Kailera Clinical Site, Chickasha
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 3 Sep 2026 · NCT07284875Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
- Kailera Clinical Site, Norman
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Sep 2026 · NCT07284979Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- Epic Medical Research - Oklahoma, Chickasha
- Lynn Health Science Institute, Oklahoma City
InaajiriHatua 3
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 27 Ago 2026 · NCT07575399A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Tulsa
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT07784725Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Moore
InaajiriHatua 3
Umri 18 hadi 79 · Jinsia zote · Imesasishwa 10 Ago 2026 · NCT07654361A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
- AMR Norman, Norman
- Lynn Health Science Institute, Oklahoma City
InaajiriHatua 2
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 22 Jul 2026 · NCT07477704Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
- University of Oklahoma, Norman
Inaajiri
Umri 18 hadi 45 · Wanawake · Imesasishwa 24 Jun 2026 · NCT05124808Uterine Preservation Via Lifestyle Transformation
- University of Oklahoma, Oklahoma City
InaajiriHatua 2
Umri 18 na zaidi · Wanawake · Imesasishwa 20 Jan 2026 · NCT05903131Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.